Marlinspike Therapeutics, Inc. — Form D
Marlinspike Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-02-28. The offering totals $65.0M, of which $3.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-02-28
- Form: D
- Accession: 0001914000-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $65.0M
- Amount sold: $3.5M
- Remaining: $61.5M
- Investors: 1
- Date of first sale: 2022-02-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-435285
Issuer
- Name: Marlinspike Therapeutics, Inc.
- CIK: 0001914000
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 245 MAIN STREET, CAMBRIDGE, MA, 02142
- Phone: 203-232-7865
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Raj Chopra | Director | Cambridge, MA |
| Seth Harrison | Director | Redwood City, CA |
| Alexander McCampbell | Director | Cambridge, MA |
| Joseph Yanchik | Director | San Diego, CA |
| Raj Chopra | Executive Officer | Cambridge, MA |
More